Xiaobin Wu, President and COO at BeOne Medicines Ltd. (ONC), sold 159,488 shares at $305.59 ($48.6M) on 2025-08-13, disclosed to the SEC on 2025-08-15.
Scheduled sale ($48.6M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.33 | 8,900 | $2.7M | 5.5% |
| 2 | $301.49 | 4,500 | $1.4M | 2.8% |
| 3 | $302.45 | 5,800 | $1.8M | 3.6% |
| 4 | $303.54 | 3,517 | $1.1M | 2.2% |
| 5 | $303.54 | 3,517 | $1.1M | 2.2% |
| 6 | $304.37 | 7,359 |
| $2.2M |
| 4.6% |
| 7 | $304.37 | 7,359 | $2.2M | 4.6% |
| 8 | $305.59 | 528 | $161K | 0.3% |
| 9 | $305.59 | 528 | $161K | 0.3% |
| 10 | $306.74 | 9,637 | $3.0M | 6.1% |
| 11 | $306.74 | 9,637 | $3.0M | 6.1% |
| 12 | $307.38 | 9,617 | $3.0M | 6.1% |
| 13 | $307.38 | 9,617 | $3.0M | 6.1% |
| 14 | $300.86 | 400 | $120K | 0.2% |
| 15 | $302.04 | 5,800 | $1.8M | 3.6% |
| 16 | $302.04 | 5,800 | $1.8M | 3.6% |
| 17 | $303.31 | 6,965 | $2.1M | 4.3% |
| 18 | $303.31 | 6,965 | $2.1M | 4.3% |
| 19 | $304.19 | 500 | $152K | 0.3% |
| 20 | $305.48 | 8,522 | $2.6M | 5.4% |
| 21 | $305.48 | 8,522 | $2.6M | 5.4% |
| 22 | $306.26 | 12,232 | $3.7M | 7.7% |
| 23 | $306.26 | 12,232 | $3.7M | 7.7% |
| 24 | $307.43 | 4,917 | $1.5M | 3.1% |
| 25 | $307.43 | 4,917 | $1.5M | 3.1% |
| 26 | $308.03 | 600 | $185K | 0.4% |
| 27 | $308.03 | 600 | $185K | 0.4% |
| Total | $304.97 avg | 159,488 | $48.6M | 100% |
| Filing → |
| ONC | SELL | 2026-06-18 | $362K | — | Filing → |
| ONC | SELL | 2026-06-15 | $164K | — | Filing → |
| ONC | SELL | 2026-06-10 | $400K | — | Filing → |